Aeglea Biotherapeutics shares owned by Cormorant Asset Management
Quarter-by-quarter ownership of Aeglea Biotherapeutics (SYRE) shares owned by Cormorant Asset Management
from 13F filings
Historical chart of Cormorant Asset Management investment in Aeglea Biotherapeutics
Tip: Access up to 7 years of quarterly data
All positions including Aeglea Biotherapeutics held by Cormorant Asset Management consolidated in one spreadsheet with up to 7 years of data
Download as csv Download as ExcelQuarterly reported holdings in Aeglea Biotherapeutics by Cormorant Asset Management
Quarter filed | Position value | Share count | Share price at filing |
---|---|---|---|
2023-12-31 | $20M | 937k | 21.52 |
More positions owned by Cormorant Asset Management
View all positions for Cormorant Asset Management